SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 14.27% in the revenue at Rs. 38234.00 millions was reported in the September 2021 quarter as compared to Rs. 33458.00 millions during year-ago period.The Net proft of the company remain more or less same to Rs. 4490.00  millions from Rs. 4810.00 millions ,decline by -6.65%.Operating profit for the quarter ended September 2021 rose to 8664.00 millions as compared to 8432.00 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 38234.00 33458.00 14.27 72569.00 65902.00 10.12 133491.00 118504.00 12.65
Other Income 1181.00 266.00 343.98 3043.00 6713.00 -54.67 8011.00 7432.00 7.79
PBIDT 8664.00 8432.00 2.75 16145.00 24166.00 -33.19 39379.00 36128.00 9.00
Interest 111.00 93.00 19.35 176.00 233.00 -24.46 467.00 478.00 -2.30
PBDT 8553.00 8339.00 2.57 15969.00 23933.00 -33.28 38912.00 35650.00 9.15
Depreciation 2066.00 2142.00 -3.55 4037.00 4119.00 -1.99 8350.00 7892.00 5.80
PBT 6487.00 6197.00 4.68 11932.00 19814.00 -39.78 30562.00 27758.00 10.10
TAX 1997.00 1387.00 43.98 3308.00 5502.00 -39.88 8698.00 -1619.00 -637.25
Deferred Tax 841.00 273.00 208.06 1168.00 1997.00 -41.51 3297.00 -6458.00 -151.05
PAT 4490.00 4810.00 -6.65 8624.00 14312.00 -39.74 21864.00 29377.00 -25.57
Equity 832.00 831.00 0.12 832.00 831.00 0.12 832.00 831.00 0.12
PBIDTM(%) 22.66 25.20 -10.08 22.25 36.67 -39.33 29.50 30.49 -3.24

Dr. Reddys Labs. Share Price

1376.30 26.30 (1.95%)
29-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1872.60
Dr. Reddys Labs. 1376.30
Cipla 1453.50
Zydus Lifesciences 1121.65
Lupin 2407.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: